The p53 mt-positive staining rate in the NSCLC tissue was 39.2% (51/130 patients) and the correlation between positive expression and the clinicopathological characteristics of the patients with NSCLC are summarized in Table I. The gene discussed is TP53; the disease is non-small cell lung carcinoma.